vs
CarGurus, Inc.（CARG）与科睿唯安（CLVT）财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是CarGurus, Inc.的3.0倍（$617.0M vs $209.1M）。CarGurus, Inc.净利率更高（23.8% vs 0.5%，领先23.3%）。科睿唯安同比增速更快（-6.9% vs -8.5%）。科睿唯安自由现金流更多（$89.2M vs $81.9M）。过去两年科睿唯安的营收复合增速更高（-0.3% vs -1.6%）
CarGurus是一家汽车研究与选购平台，在美国、英国和加拿大开展业务，为消费者和汽车经销商提供新二手车本地车源对比服务，同时支持用户与卖家直接联系，帮助购车群体高效适配心仪车辆，也为经销商搭建了精准的客户对接渠道。
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
CARG vs CLVT — 直观对比
营收规模更大
CLVT
是对方的3.0倍
$209.1M
营收增速更快
CLVT
高出1.6%
-8.5%
净利率更高
CARG
高出23.3%
0.5%
自由现金流更多
CLVT
多$7.3M
$81.9M
两年增速更快
CLVT
近两年复合增速
-1.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $209.1M | $617.0M |
| 净利润 | $49.8M | $3.1M |
| 毛利率 | — | 66.8% |
| 营业利润率 | 57.0% | 6.7% |
| 净利率 | 23.8% | 0.5% |
| 营收同比 | -8.5% | -6.9% |
| 净利润同比 | 8.5% | 101.6% |
| 每股收益（稀释后） | $0.51 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CARGCLVT
| Q4 25 | $209.1M | $617.0M | ||
| Q3 25 | $238.7M | $623.1M | ||
| Q2 25 | $234.0M | $621.4M | ||
| Q1 25 | $225.2M | $593.7M | ||
| Q4 24 | $228.5M | $663.0M | ||
| Q3 24 | $231.4M | $622.2M | ||
| Q2 24 | $218.7M | $650.3M | ||
| Q1 24 | $215.8M | $621.2M |
净利润CARGCLVT
| Q4 25 | $49.8M | $3.1M | ||
| Q3 25 | $44.7M | $-28.3M | ||
| Q2 25 | $22.3M | $-72.0M | ||
| Q1 25 | $39.0M | $-103.9M | ||
| Q4 24 | $45.9M | $-191.8M | ||
| Q3 24 | $22.5M | $-65.6M | ||
| Q2 24 | $-68.7M | $-304.3M | ||
| Q1 24 | $21.3M | $-75.0M |
毛利率CARGCLVT
| Q4 25 | — | 66.8% | ||
| Q3 25 | 89.5% | 65.0% | ||
| Q2 25 | 87.3% | 67.2% | ||
| Q1 25 | 88.7% | 65.1% | ||
| Q4 24 | 87.1% | 65.7% | ||
| Q3 24 | 78.9% | 66.2% | ||
| Q2 24 | 83.4% | 67.2% | ||
| Q1 24 | 81.1% | 64.9% |
营业利润率CARGCLVT
| Q4 25 | 57.0% | 6.7% | ||
| Q3 25 | 22.9% | 7.1% | ||
| Q2 25 | 10.6% | 1.1% | ||
| Q1 25 | 20.3% | -3.5% | ||
| Q4 24 | 23.3% | -9.4% | ||
| Q3 24 | 11.9% | 3.5% | ||
| Q2 24 | -42.8% | -36.9% | ||
| Q1 24 | 12.2% | 0.8% |
净利率CARGCLVT
| Q4 25 | 23.8% | 0.5% | ||
| Q3 25 | 18.7% | -4.5% | ||
| Q2 25 | 9.5% | -11.6% | ||
| Q1 25 | 17.3% | -17.5% | ||
| Q4 24 | 20.1% | -28.9% | ||
| Q3 24 | 9.7% | -10.5% | ||
| Q2 24 | -31.4% | -46.8% | ||
| Q1 24 | 9.9% | -12.1% |
每股收益（稀释后）CARGCLVT
| Q4 25 | $0.51 | $0.00 | ||
| Q3 25 | $0.45 | $-0.04 | ||
| Q2 25 | $0.22 | $-0.11 | ||
| Q1 25 | $0.37 | $-0.15 | ||
| Q4 24 | $0.45 | $-0.27 | ||
| Q3 24 | $0.21 | $-0.09 | ||
| Q2 24 | $-0.66 | $-0.46 | ||
| Q1 24 | $0.20 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $190.5M | $329.2M |
| 总债务越低越好 | $0 | $4.3B |
| 股东权益账面价值 | $374.2M | $4.8B |
| 总资产 | $661.9M | $11.1B |
| 负债/权益比越低杠杆越低 | 0.00× | 0.89× |
8季度趋势，按日历期对齐
现金及短期投资CARGCLVT
| Q4 25 | $190.5M | $329.2M | ||
| Q3 25 | $178.8M | $318.7M | ||
| Q2 25 | $231.2M | $362.6M | ||
| Q1 25 | $172.9M | $354.0M | ||
| Q4 24 | $304.2M | $295.2M | ||
| Q3 24 | $246.7M | $388.5M | ||
| Q2 24 | $216.2M | $376.4M | ||
| Q1 24 | $246.3M | $361.8M |
总债务CARGCLVT
| Q4 25 | $0 | $4.3B | ||
| Q3 25 | $0 | $4.4B | ||
| Q2 25 | $0 | $4.5B | ||
| Q1 25 | $0 | $4.5B | ||
| Q4 24 | $0 | $4.5B | ||
| Q3 24 | $0 | $4.6B | ||
| Q2 24 | $0 | $4.6B | ||
| Q1 24 | $0 | $4.6B |
股东权益CARGCLVT
| Q4 25 | $374.2M | $4.8B | ||
| Q3 25 | $375.4M | $4.9B | ||
| Q2 25 | $435.5M | $5.0B | ||
| Q1 25 | $402.1M | $5.0B | ||
| Q4 24 | $541.7M | $5.1B | ||
| Q3 24 | $483.5M | $5.5B | ||
| Q2 24 | $452.1M | $5.6B | ||
| Q1 24 | $568.4M | $5.9B |
总资产CARGCLVT
| Q4 25 | $661.9M | $11.1B | ||
| Q3 25 | $660.5M | $11.2B | ||
| Q2 25 | $726.1M | $11.4B | ||
| Q1 25 | $689.1M | $11.5B | ||
| Q4 24 | $824.5M | $11.5B | ||
| Q3 24 | $778.2M | $12.0B | ||
| Q2 24 | $753.3M | $12.1B | ||
| Q1 24 | $870.8M | $12.5B |
负债/权益比CARGCLVT
| Q4 25 | 0.00× | 0.89× | ||
| Q3 25 | 0.00× | 0.90× | ||
| Q2 25 | 0.00× | 0.90× | ||
| Q1 25 | 0.00× | 0.90× | ||
| Q4 24 | 0.00× | 0.88× | ||
| Q3 24 | 0.00× | 0.84× | ||
| Q2 24 | 0.00× | 0.83× | ||
| Q1 24 | 0.00× | 0.79× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $83.1M | $159.9M |
| 自由现金流经营现金流 - 资本支出 | $81.9M | $89.2M |
| 自由现金流率自由现金流/营收 | 39.2% | 14.5% |
| 资本支出强度资本支出/营收 | 0.6% | 11.5% |
| 现金转化率经营现金流/净利润 | 1.67× | 51.58× |
| 过去12个月自由现金流最近4个季度 | $288.9M | $365.3M |
8季度趋势，按日历期对齐
经营现金流CARGCLVT
| Q4 25 | $83.1M | $159.9M | ||
| Q3 25 | $71.2M | $181.1M | ||
| Q2 25 | $73.1M | $116.3M | ||
| Q1 25 | $67.9M | $171.2M | ||
| Q4 24 | $75.7M | $141.3M | ||
| Q3 24 | $56.2M | $202.9M | ||
| Q2 24 | $71.6M | $126.2M | ||
| Q1 24 | $52.0M | $176.2M |
自由现金流CARGCLVT
| Q4 25 | $81.9M | $89.2M | ||
| Q3 25 | $69.8M | $115.5M | ||
| Q2 25 | $71.5M | $50.3M | ||
| Q1 25 | $65.6M | $110.3M | ||
| Q4 24 | $65.5M | $59.1M | ||
| Q3 24 | $45.9M | $126.3M | ||
| Q2 24 | $45.6M | $60.3M | ||
| Q1 24 | $23.3M | $111.8M |
自由现金流率CARGCLVT
| Q4 25 | 39.2% | 14.5% | ||
| Q3 25 | 29.2% | 18.5% | ||
| Q2 25 | 30.6% | 8.1% | ||
| Q1 25 | 29.2% | 18.6% | ||
| Q4 24 | 28.7% | 8.9% | ||
| Q3 24 | 19.8% | 20.3% | ||
| Q2 24 | 20.9% | 9.3% | ||
| Q1 24 | 10.8% | 18.0% |
资本支出强度CARGCLVT
| Q4 25 | 0.6% | 11.5% | ||
| Q3 25 | 0.6% | 10.5% | ||
| Q2 25 | 0.7% | 10.6% | ||
| Q1 25 | 1.0% | 10.3% | ||
| Q4 24 | 4.5% | 12.4% | ||
| Q3 24 | 4.4% | 12.3% | ||
| Q2 24 | 11.9% | 10.1% | ||
| Q1 24 | 13.3% | 10.4% |
现金转化率CARGCLVT
| Q4 25 | 1.67× | 51.58× | ||
| Q3 25 | 1.59× | — | ||
| Q2 25 | 3.27× | — | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | 1.65× | — | ||
| Q3 24 | 2.50× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.44× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CARG
| US | $187.0M | 89% |
| Non Us | $22.1M | 11% |
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
